Molecular Biology Service Market Report 2026

The molecular biology service market size has grown strongly in recent years. It will grow from $5.05 billion in 2025 to $5.46 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to increasing adoption of pcr-based testing, growing use of sequencing services in research, rising academic and clinical r&d activities, expansion of molecular diagnostics applications, increasing outsourcing of laboratory services.

The molecular biology service market size is expected to see strong growth in the next few years. It will grow to $7.36 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing demand for precision medicine services, increasing investment in genomic research, rising adoption of automated molecular workflows, expansion of clinical diagnostic testing volumes, increasing utilization of next-generation sequencing services and Major trends in the forecast period include technology advancements in sequencing platforms, innovations in automated molecular workflows, developments in bioinformatics and data analytics, research and development in precision diagnostics, advancements in high-throughput molecular testing systems.

The rising prevalence of infectious diseases is expected to drive the growth of the molecular biology service market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that invade the body, multiply, and lead to symptoms and health complications. The increase in infectious diseases is fueled by factors such as global travel, which accelerates the spread of pathogens across populations and borders. Molecular biology services support infectious disease diagnosis by providing specialized testing, analysis, and interpretation of genetic and molecular data. They enhance patient care by enabling accurate and timely pathogen detection and supporting informed treatment decisions. For example, in February 2024, according to the UK Health Security Agency, a UK-based government body, tuberculosis cases in England rose to 4,850 in 2023, representing a 10.7% increase from 4,380 cases in 2022. Therefore, the growing prevalence of infectious diseases is contributing to the expansion of the molecular biology service market.

Major companies operating in the molecular biology service market are concentrating on developing advanced molecular biology techniques, such as CRISPR-based microbial genome editing, to meet the growing demand for precise molecular modification and analysis. CRISPR-based microbial gene-editing services assist researchers by enabling accurate editing, modification, and functional analysis of DNA sequences using tools like CRISPR/Cas systems, thereby enhancing experimental design, validation, and analysis within molecular workflows. For example, in June 2025, Creative Diagnostics, a US-based provider of molecular services, introduced advanced microbial genome-editing services featuring high-precision CRISPR editing with optimized sgRNA design, support for multigene editing, and comprehensive validation, including RT-PCR and Western blot quality assurance. These enhanced services enable research institutions and biotech companies to perform efficient genome manipulation and conduct robust molecular investigations.

In May 2024, Bruker Corporation, an Italy-based provider of high-performance scientific instruments and analytical solutions, acquired ELITechGroup S.p.A. for approximately $1.02 billion (€870 million). Through this acquisition, Bruker expanded its molecular biology and in vitro diagnostics portfolio by incorporating ELITech’s sample-to-answer molecular diagnostic systems and assays, strengthening its capabilities in infectious disease testing and biomedical solutions. ELITechGroup S.p.A. is a France-based in vitro diagnostics (IVD) company specializing in molecular biology services and solutions.

Major companies operating in the molecular biology service market are Thermo Fisher Scientific Inc., Illumina Inc., Labcorp Drug Development, PerkinElmer Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., QIAGEN N.V., Roche Diagnostics International Ltd., WuXi AppTec Co. Ltd., Sangon Biotech Co. Ltd., Azenta Life Sciences, BGI Genomics Co. Ltd., BGI Americas Corporation, Promega Corporation, Macrogen Inc., MedGenome Labs Ltd., Genscript ProBio, Biomarker Technologies Corporation, CeGaT GmbH, Veritas Genetics Inc., LC Sciences LLC, Arraystar Inc.

North America was the largest region in the molecular biology service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular biology service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the molecular biology service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the molecular biology services market by increasing costs of imported reagents, sequencing instruments, analytical consumables, and laboratory automation systems. research institutions and biotechnology companies in north america and europe are most affected due to dependence on globally sourced laboratory supplies, while asia-pacific faces cost pressures on service scalability. these tariffs are raising service pricing and extending project timelines. however, they are also encouraging local sourcing of reagents, regional lab expansion, and development of cost-efficient in-house molecular analysis capabilities.

Molecular biology service refers to professional laboratory services that employ molecular biology techniques, including DNA and RNA analysis, gene expression profiling, sequencing, and protein studies, to support research, diagnostics, and biotechnology applications. Its primary purpose is to deliver precise molecular-level insights for drug discovery, disease research, and genetic analysis, facilitating faster and more accurate scientific results.

The primary service types in molecular biology services include DNA/RNA extraction, PCR and qPCR services, sequencing services, gene synthesis, cloning, genotyping, proteomics, cell line development, and others. DNA/RNA extraction services isolate high-quality genetic material from samples such as blood, tissues, cells, and microorganisms, forming the foundation for downstream testing. Applications include diagnostics, drug discovery, agriculture, environmental research, forensic science, and others, serving research institutes, pharmaceutical and biotech firms, hospitals, diagnostic labs, CROs, and others.

The molecular biology service market consists of revenues earned by entities by providing services such as DNA sequencing, RNA sequencing, polymerase chain reaction (PCR) analysis, gene expression profiling, molecular cloning, genotyping, protein analysis, molecular diagnostics, bioinformatics analysis, and next-generation sequencing (NGS) services. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular biology service market also includes sales of DNA extraction kits, RNA extraction kits, PCR reagents, molecular biology enzymes, sequencing kits, cloning kits, electrophoresis equipment, laboratory consumables, nucleic acid purification kits, and molecular biology assay kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.